New gel injection aims to smooth cheek wrinkles

NCT ID NCT07153237

Not yet recruiting Symptom relief Sponsor: Laboratoires Vivacy Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests STYLAGE® HydroMax, a gel made of hyaluronic acid, to see how well it reduces superficial wrinkles on the cheeks. About 81 adults aged 35 to 70 with mild to moderate wrinkles will receive three injection sessions over 24 weeks. The main goal is to measure wrinkle improvement using a standard scale.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hyaluronic acid gel (STYLAGE® HydroMax)
What this could lead to: If it works, this could offer a safe and effective option for reducing superficial cheek wrinkles.
What could go wrong: This is a post-market study, so the product is already available. The main risk is that results may not show significant improvement over existing treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AESTHETIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AESTHETIC AGING

Contacts and locations

Locations

Eurofins DERMSCAN

Aix-en-Provence, 13290, France
Eurofins DERMSCAN PHARMASCAN

Villeurbanne, 69100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.